Gene · 23462
Papers3,005
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,005
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Response of Osteoblasts on Amine-Based Nanocoatings Correlates with the Amino Group Density. | Molecules | 2023 | 37764281 | PubTator, text mining | PubMed |
| A Review of the Molecular Landscape of Adenoid Cystic Carcinoma of the Lacrimal Gland. | Int J Mol Sci | 2023 | 37762061 | PubTator, text mining | PubMed |
| Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis. | Biomedicines | 2023 | 37760975 | PubTator, text mining | PubMed |
| Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials. | Cancers (Basel) | 2023 | 37760551 | PubTator, text mining | PubMed |
| ZFP64 Promotes Gallbladder Cancer Progression through Recruiting HDAC1 to Activate NOTCH1 Signaling Pathway. | Cancers (Basel) | 2023 | 37760477 | PubTator, text mining | PubMed |
| Unveiling the Osteogenic Potential of Tetracyclines: A Comparative Study in Human Mesenchymal Stem Cells. | Cells | 2023 | 37759467 | PubTator, text mining | PubMed |
| HDAC6 and ERK/ADAM17 Regulate VEGF-Induced NOTCH Signaling in Lung Endothelial Cells. | Cells | 2023 | 37759454 | PubTator, text mining | PubMed |
| Gene regulation for inflammation and inflammation resolution differs between umbilical arterial and venous endothelial cells. | Sci Rep | 2023 | 37758738 | PubTator, text mining | PubMed |
| Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms. | Drug Des Devel Ther | 2023 | 37753228 | PubTator, text mining | PubMed |
| Aberrant differentiation of epithelial progenitors is accompanied by a hypoxic microenvironment in the paraquat-injured human lung. | Cell Discov | 2023 | 37752109 | PubTator, text mining | PubMed |
| Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia. | Nat Cancer | 2023 | 37749321 | PubTator, text mining | PubMed |
| Loss of HES1 expression is associated with extracellular matrix remodeling and tumor immune suppression in KRAS mutant colon adenocarcinomas. | Sci Rep | 2023 | 37749297 | PubTator, text mining | PubMed |
| Targetable NOTCH1 rearrangements in reninoma. | Nat Commun | 2023 | 37749094 | PubTator, text mining | PubMed |
| Clinical diagnostic and radiographic features of a primary intradural spinal chondrosarcoma in a young adult: illustrative case. | J Neurosurg Case Lessons | 2023 | 37728306 | PubTator, text mining | PubMed |
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study. | Cancer Med | 2023 | 37724607 | PubTator, text mining | PubMed |
| Knocking down SOX2 overcomes the resistance of prostate cancer to castration via notch signaling. | Mol Biol Rep | 2023 | 37716921 | PubTator, text mining | PubMed |
| A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors. | Cancer Res Commun | 2023 | 37712875 | PubTator, text mining | PubMed |
| Rosiglitazone-Mediated Activation of PPARγ Restores HO1 Expression in the Human Preeclamptic Placenta. | Hypertension | 2023 | 37702083 | PubTator, text mining | PubMed |
| A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer. | iScience | 2023 | 37694141 | PubTator, text mining | PubMed |
| Building Blood Vessel Chips with Enhanced Physiological Relevance. | Adv Mater Technol | 2023 | 37693798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23462/papers?page=11